Whilst the US Food and Drug Administration (FDA) has approved five drug therapies to treat obesity (orlistat, phentermine/topiramate, lorcaserin, naltrexone/bupropion, liraglutide), the European Medicines Agency (EMA) has approved only three drug therapies (orlistat, bupropion/naltrexone and liraglutide) [8] at the time of writing
Chavoshi Nezhad N et al
The brain contains elevated levels of 7nAChR in regions associated with cognitive function and memory, such as the hippocampus, hypothalamus, colliculi, geniculate nuclei, thalamus, cortex, medial habenula, and amygdala ( Fig
Qsymia (phentermine-topiramate): Effective but facing adoption challenges
Priority Meds is a registered business operating from Clearwater, Florida
Browse all Peptides & GLP-1 education Consider this an independent, fair-balance editorial assessment